Proposed rule by CMS would expand access to cancer treatment at tribal facilities

Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care

The Supreme Court last week upended one of the underpinnings of administrative law by weakening the authority of federal health agencies to rely on technical expertise as they regulate medical products, issue coverage decisions, and respond to public health crises.

July 05, 2024

Vol.50 No.27

By Matthew Bin Han Ong

Conversation with The Cancer Letter

Georgetown’s Zachary Baron on the post-Chevron era: We need guardrails about when agency expertise should be cast aside

The Supreme Court struck down the Chevron doctrine, removing one of the foundational principles of administrative law and upending the way federal agencies rely on technical subject-matter expertise. What comes next?

July 05, 2024

Vol.50 No.27

By Matthew Bin Han Ong

Drugs & Targets

MCW Cancer Center leads change in Medicare policy for older patients with MDS in need of alloHCT

The Centers for Medicare & Medicaid Services recently issued a decision to expand Medicare coverage for allogeneic hematopoietic stem cell transplants for eligible Medicare patients with myelodysplastic syndromes, based on decades-long research led by investigators at the Medical College of Wisconsin Cancer Center, in collaboration with investigators in the Blood and Marrow Transplant Clinical Trials Network and advocacy experts at the American Society of Hematology, American Society for Transplantation and Cellular Therapy, and the National Marrow Donor Program.

May 10, 2024

Vol.50 No.19

Guest Editorial

The growing need for cancer patient navigation and how to meet it

The process of navigating the cancer care continuum can be extremely complex, confusing, and frustrating for patients and caregivers. To achieve better outcomes, patients need to not only be aware of their options, but also have a comprehensive understanding of them and be able to act accordingly and with purpose.

January 26, 2024

Vol.50 No.04

By Alyssa Schatz and Crystal S. Denlinger

In Brief

ASCO expresses support for CMS rule establishing electronic prior authorization in federal health plans

The Centers for Medicare & Medicaid Services issued its rule requiring federal health plans—including Medicare Advantage plans, Medicaid plans, and Qualified Health Plans on Federally Facilitated Exchanges—to establish an electronic prior authorization process that will be integrated into providers’ workflows.

January 19, 2024

Vol.50 No.03

In Brief

National Association for Proton Therapy expresses support for CMS rule to improve prior authorization

The National Association for Proton Therapy commended CMS for ensuring seniors have timely access to medical care, especially advanced cancer treatments, through the Advancing Interoperability and Improving Prior Authorization Processes, or e-PA, Rule.

January 19, 2024

Vol.50 No.03

Proposed rule by CMS would expand access to cancer treatment at tribal facilities

YOU MAY BE INTERESTED IN

Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care

Georgetown’s Zachary Baron on the post-Chevron era: We need guardrails about when agency expertise should be cast aside

MCW Cancer Center leads change in Medicare policy for older patients with MDS in need of alloHCT

The growing need for cancer patient navigation and how to meet it

ASCO expresses support for CMS rule establishing electronic prior authorization in federal health plans

National Association for Proton Therapy expresses support for CMS rule to improve prior authorization

Renew today!

Subscriber content

Login